Dentistry and Oral Surgery

Cheng YS, Wright JM, Walstad WR, Finn MD. Calcifying epithelial odontogenic tumor showing microscopic features of potential malignant behavior. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:287–295.

Del Santo M Jr, English JD, Wolford LM, Gandini LG Jr. Midsymphyseal distraction osteogenesis for correcting transverse mandibular discrepancies. Am J Orthod Dentofacial Orthop 2002;121:629–638.

Ghali GE, Tharanon W, Sinn DP. Craniofacial deformities: introduction in principles of management. In Greenberg A, Prein J, eds. Craniofacial Reconstruction and Corrective Bone Surgery. New York: Springer-Verlag, 2002.

Henry CH, Nikaein A, Wolford LM. Analysis of human leukocyte antigens in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 2002;60:778–783.

Mehra P, Castro V, Freitas RZ, Wolford LM. Stability of the Le Fort I osteotomy for maxillary advancement using rigid fixation and porous block hydroxyapatite grafting. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:18–23.

Mercuri LG, Wolford LM, Sanders B, White RD, Giobbie-Hurder A. Long-term follow-up of the CAD/CAM patient fitted total temporomandibular joint reconstruction system. J Oral Maxillofac Surg 2002;60:1440–1448.

Parel SM, Ruff SL, Triplett RG, Schow SR. Bone reduction surgical guide for the Novum implant procedure: technical note. Int J Oral Maxillofac Implants 2002;17:715–719.

Tantipasawasin S, Sinn DP, Ghali GE. Management of syndromic craniosynostosis. Atlas Oral Maxillofac Surg Clin North Am 2002;10:101–130.

Veltkamp T, Buschang PH, English JD, Bates J, Schow SR. Predicting lower lip and chin response to mandibular advancement and genioplasty. Am J Orthod Dentofacial Orthop 2002;122:627–634.

Wolford LM. Identifying the functional and esthetic factors associated with dentofacial deformities. Tex Dent J 2002;119:1034–1043.

Wolford LM, Karras S, Mehra P. Concomitant temporomandibular joint and orthognathic surgery: a preliminary report. J Oral Maxillofac Surg 2002;60:356–362.

Wolford LM, Mehra P. The timing of third molar removal in patients undergoing a bilateral sagittal split osteotomy. J Oral Maxillofac Surg 2002;60:132–133.

Wolford LM, Mehra P, Franco P. Use of conservative condylectomy for treatment of osteochondroma of the mandibular condyle. J Oral Maxillofac Surg 2002;60:262–268.

Wolford LM, Mehra P, Reiche-Fischel O, Morales-Ryan CA, Garcia-Morales P. Efficacy of high condylectomy for management of condylar hyperplasia. Am J Orthod Dentofacial Orthop 2002;121:136–150.

Wolford LM, Rieche-Fischel O, Mehra P. Soft tissue healing after parasagittal palatal incisions in segmental maxillary surgery: a review of 311 patients. J Oral Maxillofac Surg 2002;60:20–25.

Wolford LM, Stevao ELL. Correction of jaw deformities in patients with cleft lip and palate. BUMC Proceedings 2002;15:250–254.

Abdelmalek NF, Gerber TL, Menter A. Cardiocutaneous syndromes and associations. J Am Acad Dermatol 2002;46:161–183.

Abramovits W, Abdelmalek N. Treatment of warty dyskeratoma with tazarotenic acid. J Am Acad Dermatol 2002;46(2 Suppl Case Reports):S4.

Abramovits W, Goldstein AM, Gonzalez S. Confocal microscopy oriented cryosurgery. Int J Dermatol 2002;41:284–285.

Bandel C, DePrisco G, Cockerell CJ, Ehrig T. Abundance of interstitial heparan sulfate in granuloma annulare but not in other mucinous skin diseases. J Cutan Pathol 2002;29:524–528.

Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, Walker P, Eadie N. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840–849.
Cather JC, Cather JC, Menter A. Update on botulinum toxin for facial aesthetics. Dermatol Clin 2002;20:749–761.

Cather JC, Cather JC, Menter MA. Meandering linear pruritic lesion. BUMC Proceedings 2002;15:219–220.

Cather J, Menter A. Novel therapies for psoriasis. Am J Clin Dermatol 2002;3:159–173.
Cather JC, Menter MA. Leg lesions and velvety hyperpigmentation on the neck. BUMC Proceedings 2002;15:327–328.

Cather JC, Menter MA. Vesicular eruption including the mouth. BUMC Proceedings 2002;15:93–94.

Cather JC, Vance EA, Menter MA. Diverse cutaneous manifestations associated with a single disease. BUMC Proceedings 2002;15:433–436.

Curry ML, Curry JA, Cockerell CJ. Dermatology and the Americans With Disabilities Act: a review of the case law. J Am Acad Dermatol 2002;47:926–929.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002;46:361–370.

Howell JB, Freeman RG. The potential peril from caliber-persistent arteries of the lips. J Am Acad Dermatol 2002;46:256–259.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 2002;41:269–274.

Lee HJ, Ha SJ, Lee JH, Kim JW, Kim HO, Whiting DA. Hair counts from scalp biopsy specimens in Asians. J Am Acad Dermatol 2002;46:218–221.

Menter A. Tazarotene in women. Skin and Allergy News, January 2002.

Olsen EA, Hordinsky M, Roberts JL, Whiting DA. Female pattern hair loss. J Am Acad Dermatol 2002;47:795.

Tosti A, Piraccini BM, Bergfeld WF, Camacho F, Dawber RP, Happle R, Olsen EA, Price VH, Rebora A, Shapiro J, Sinclair R, Vanneste D, Whiting DA. Occupational alopecia or alopecia areata? J Am Acad Dermatol 2002;47:636–637.

Wang L, Eng W, Cockerell CJ. Effects of ultraviolet irradiation on inflammation in the skin. Adv Dermatol 2002;18:247–286.

Warren SJ, Cockerell CJ. Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features. Am J Dermatopathol 2002;24:305–308.

Weiss J, Menter A, Hevia O, Jones T, Ling M, Rist T, Roberts J, Shavin JS, Sklar J, Webster G, Connolly M, Furst K, Levy S. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis 2002;70(2 Suppl):22–29.